D-1179-2018 Class I Terminated

Recalled by Westminster Pharmaceuticals LLC — Olive Branch, MS

FDA drug recall D-1179-2018 was initiated by Westminster Pharmaceuticals LLC on Aug 3, 2018 and is designated Class I. Reason for recall: Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices… The recall status is terminated (terminated Jun 3, 2020).

Recall details

Product Type
Drugs
Report Date
Aug 29, 2018
Initiation Date
Aug 3, 2018
Termination Date
Jun 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.

Reason for recall

Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.

Distribution pattern

Nationwide in the USA and Puerto Rico

Code information

Lot #: 15717VP-01, 15717VP-02, 15717VP-03, Exp 7/31/2019; 15717002, Exp 12/31/2019; 15718004, Exp 3/31/2020.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1179-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1179-2018. Report a data issue: hello@regdatalab.com.